stocktools
Offerings // Dermata Therapeutics, Inc.

DRMAW offering history

Every offering-related filing in Dermata Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 362 filings back to Apr 2, 2021.

Last executed offering
Jan 27, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
May 22, 2026
S-3/A — capacity, not a sale
Executed, last 12 months
3
424B pricings + 8-K 3.02 sales
Registered, last 12 months
3
S-1/S-3/F-series registrations
DateFilingWhat it means
May 29, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 29, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 22, 2026S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Jan 29, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 29, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 27, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 22, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Dec 29, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Nov 24, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Nov 7, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 23, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 23, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 15, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Mar 28, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 5, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Feb 5, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 30, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jan 23, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 24, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 24, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 19, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Sep 17, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Aug 2, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 15, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 12, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 3, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jun 7, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 17, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 15, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 15, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 7, 2023S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Nov 17, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jul 27, 2023424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 27, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 7, 2023S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
May 25, 2023424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 24, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 21, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 20, 2023424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Mar 16, 2023S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
DRMAW offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full DRMAW workspace →
DRMAW offering FAQ

When did DRMAW last execute an offering?

Per SEC filings, Dermata Therapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2026-01-27. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did DRMAW last announce or register an offering?

The most recent registration is a S-3/A filed 2026-05-22. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.